Collett, Andrew, Tanianis-Hughes, Jola, Hallifax, David and Warhurst, Geoff (2004) Predicting P-Glycoprotein Effects on Oral Absorption: Correlation of Transport in Caco-2 with Drug Pharmacokinetics in Wild-Type and mdr1a(-/-) Mice in Vivo. Pharmaceutical Research, 21 (5). pp. 819-826. ISSN 0724-8741Metadata only available from this repository.
Purpose. Cell-based permeability screens are widely used to identify drug-P-glycoprotein (PGP) interaction in vitro. However, their reliability in predicting the impact of PGP on human drug pharmacokinetics is poorly defined. The aim was to determine whether a quantitative relationship exists between PGP-mediated alterations in Caco-2 permeability and oral pharmacokinetics in mice.
Methods. Two indicators of drug efflux were measured in Caco-2 for a group of 10 compounds, the ratio of A-B and B-A transport (RB-A/A-B) and the ratio of A-B transport in the presence and absence of a PGP inhibitor, GF120918 (RGF). These data were correlated with ratios of oral plasma levels in either mdr1a(-/-) or mdr1a/1b(-/-) and wild-type mice (RKO/WT in vivo) calculated from literature data on these compounds.
Results. A significant, positive correlation (r2= 0.8, p \h 0.01) was observed between RGF and RKO/WT in vivo. In contrast, RB-A/A-B, a more commonly used in vitro measure, showed a much weaker correlation with in vivo data (r2= 0.33, p = 0.11). A strong correlation with RGF was also observed after correction of in vivo data for PGP effects on IV clearance.
Conclusion. The increase in A-B drug permeability following inhibition of PGP in Caco-2 allows a reasonable prediction of the likely in vivo impact that PGP will have on plasma drug levels after oral administration.
|Subjects:||R Medicine > RZ Other systems of medicine|
Q Science > QH Natural history > QH301 Biology
|Schools:||School of Applied Sciences|
|Depositing User:||Cherry Edmunds|
|Date Deposited:||20 Aug 2009 11:45|
|Last Modified:||20 Aug 2009 11:45|
Repository Staff Only: item control page